Advertisement

A flavonoid-rich extract from bergamot juice prevents carcinogenesis in a genetic model of colorectal cancer, the Pirc rat (F344/NTac-Apcam1137)

  • Michele NavarraEmail author
  • Angelo Pietro Femia
  • Andrea Romagnoli
  • Katia Tortora
  • Cristina Luceri
  • Santa Cirmi
  • Nadia Ferlazzo
  • Giovanna Caderni
Original Contribution

Abstract

Purpose

To determine the potential of a flavonoid-rich extract from bergamot juice (BJe) to prevent colorectal carcinogenesis (CRC) in vivo.

Main methods

Pirc rats (F344/NTac-Apcam1137), mutated in Apc, the key gene in CRC, were treated with two different doses of BJe (35 mg/kg or 70 mg/kg body weight, respectively) mixed in the diet for 12 weeks. Then, the entire intestine was surgically removed and dissected for histological, immunohistochemical and molecular analyses.

Results

Rats treated with BJe showed a significant dose-related reduction in the colon preneoplastic lesions mucin-depleted foci (MDF). Colon and small intestinal tumours were also significantly reduced in rats supplemented with 70 mg/kg of BJe. To elucidate the involved mechanisms, markers of inflammation and apoptosis were determined. Compared to controls, colon tumours from BJe 70 mg/kg-supplemented rats showed a significant down-regulation of inflammation-related genes (COX-2, iNOS, IL-1β, IL-6 and IL-10 and Arginase 1). Moreover, in colon tumours from rats fed with 70 mg/kg BJe, apoptosis was significantly higher than in controls. Up-regulation of p53 and down-regulation of survivin and p21 genes was also observed.

Conclusions

These data indicate a strong chemopreventive activity of BJe that, at least in part, is due to its pro-apoptotic and anti-inflammatory actions. This effect could be exploited as a strategy to prevent CRC in high-risk patients.

Keywords

Bergamot juice Citrus bergamia Cancer Colon carcinogenesis Inflammation 

Abbreviations

BJ

Bergamot juice

BJe

Flavonoid-rich extract from bergamot juice

SCID

Severe combined immunodeficiency

CRC

Colorectal cancer

NM

Normal mucosa

PCNA

Proliferating cell nuclear antigen

MDF

Mucin-depleted foci

FAP

Familial adenomatous polyposis

BW

Body weight

Notes

Acknowledgements

Research was supported by Grants from Calabria Region (PSR Calabria 2007/2013 misura 124, project “ABSIB”) and University of Florence (Fondo ex-60). A fellowship from the “Prof. Antonio Imbesi” Foundation, Messina, Italy to S. Cirmi is gratefully acknowledged.

Author contributions

APF carried out the carcinogenesis and the histochemistry experiments, KT maintained the Pirc colony and, together with AR and CL, carried out part of the carcinogenesis experiment. GC determined apoptosis and proliferation in immunohistochemistry. SC and NF performed real-time PCR analyses. GC and MN conceived, designed and supervised the work, as well as drafted the manuscript, that was read and approved by all the authors.

Compliance with ethical standards

Conflict of interest

The authors declared that are no conflicts of interest. Agrumaria Corleone provided BJe, but it had no other role in the study.

Ethical standards

The animal studies have been approved by the Commission for Animal Experimentation of the Italian Ministry of Health (Authorization number 323/2016-PR) and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

References

  1. 1.
    Mannucci C, Navarra M, Calapai F, Squeri R, Gangemi S, Calapai G (2017) Clinical pharmacology of Citrus bergamia: a systematic review. Phytother Res 31(1):27–39.  https://doi.org/10.1002/ptr.5734 CrossRefGoogle Scholar
  2. 2.
    Navarra M, Mannucci C, Delbo M, Calapai G (2015) Citrus bergamia essential oil: from basic research to clinical application. Front Pharmacol 6:36.  https://doi.org/10.3389/fphar.2015.00036 CrossRefGoogle Scholar
  3. 3.
    Navarra M, Ferlazzo N, Cirmi S, Trapasso E, Bramanti P, Lombardo GE, Minciullo PL, Calapai G, Gangemi S (2015) Effects of bergamot essential oil and its extractive fractions on SH-SY5Y human neuroblastoma cell growth. J Pharm Pharmacol 67(8):1042–1053.  https://doi.org/10.1111/jphp.12403 CrossRefGoogle Scholar
  4. 4.
    Ferlazzo N, Cirmi S, Calapai G, Ventura-Spagnolo E, Gangemi S, Navarra M (2016) Anti-inflammatory activity of Citrus bergamia derivatives: where do we stand? Molecules.  https://doi.org/10.3390/molecules21101273 Google Scholar
  5. 5.
    Delle Monache S, Sanita P, Trapasso E, Ursino MR, Dugo P, Russo M, Ferlazzo N, Calapai G, Angelucci A, Navarra M (2013) Mechanisms underlying the anti-tumoral effects of Citrus bergamia juice. PloS One 8(4):e61484.  https://doi.org/10.1371/journal.pone.0061484 CrossRefGoogle Scholar
  6. 6.
    Ferlazzo N, Cirmi S, Russo M, Trapasso E, Ursino MR, Lombardo GE, Gangemi S, Calapai G, Navarra M (2016) NF-kappaB mediates the antiproliferative and proapoptotic effects of bergamot juice in HepG2 cells. Life Sci 146:81–91.  https://doi.org/10.1016/j.lfs.2015.12.040 CrossRefGoogle Scholar
  7. 7.
    Visalli G, Ferlazzo N, Cirmi S, Campiglia P, Gangemi S, Pietro AD, Calapai G, Navarra M (2014) Bergamot juice extract inhibits proliferation by inducing apoptosis in human colon cancer cells. Anticancer Agents Med Chem 14(10):1402–1413CrossRefGoogle Scholar
  8. 8.
    Navarra M, Ursino MR, Ferlazzo N, Russo M, Schumacher U, Valentiner U (2014) Effect of Citrus bergamia juice on human neuroblastoma cells in vitro and in metastatic xenograft models. Fitoterapia 95:83–92.  https://doi.org/10.1016/j.fitote.2014.02.009 CrossRefGoogle Scholar
  9. 9.
    Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49(6):1374–1403.  https://doi.org/10.1016/j.ejca.2012.12.027 CrossRefGoogle Scholar
  10. 10.
    Li Y, Zhang T, Chen GY (2018) Flavonoids and colorectal cancer prevention. Antioxidants (Basel).  https://doi.org/10.3390/antiox7120187 Google Scholar
  11. 11.
    Cirmi S, Maugeri A, Ferlazzo N, Gangemi S, Calapai G, Schumacher U, Navarra M (2017) Anticancer potential of citrus juices and their extracts: a systematic review of both preclinical and clinical studies. Front Pharmacol 8:420.  https://doi.org/10.3389/fphar.2017.00420 CrossRefGoogle Scholar
  12. 12.
    Cirmi S, Ferlazzo N, Lombardo GE, Maugeri A, Calapai G, Gangemi S, Navarra M (2016) Chemopreventive agents and inhibitors of cancer hallmarks: may citrus offer new perspectives? Nutrients.  https://doi.org/10.3390/nu8110698 Google Scholar
  13. 13.
    Cirmi S, Navarra M, Woodside JV, Cantwell MM (2018) Citrus fruits intake and oral cancer risk: a systematic review and meta-analysis. Pharmacol Res 133:187–194.  https://doi.org/10.1016/j.phrs.2018.05.008 CrossRefGoogle Scholar
  14. 14.
    Amos-Landgraf JM, Kwong LN, Kendziorski CM, Reichelderfer M, Torrealba J, Weichert J, Haag JD, Chen KS, Waller JL, Gould MN, Dove WF (2007) A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer. Proc Natl Acad Sci USA 104(10):4036–4041.  https://doi.org/10.1073/pnas.0611690104 CrossRefGoogle Scholar
  15. 15.
    Femia AP, Luceri C, Soares PV, Lodovici M, Caderni G (2015) Multiple mucin depleted foci, high proliferation and low apoptotic response in the onset of colon carcinogenesis of the PIRC rat, mutated in Apc. Int J Cancer 136(6):E488–E495.  https://doi.org/10.1002/ijc.29232 CrossRefGoogle Scholar
  16. 16.
    Ricciardiello L, Ahnen DJ, Lynch PM (2016) Chemoprevention of hereditary colon cancers: time for new strategies. Nat Rev Gastroenterol Hepatol 13(6):352–361.  https://doi.org/10.1038/nrgastro.2016.56 CrossRefGoogle Scholar
  17. 17.
    Ferlazzo N, Visalli G, Smeriglio A, Cirmi S, Lombardo GE, Campiglia P, Di Pietro A, Navarra M (2015) Flavonoid fraction of orange and bergamot juices protect human lung epithelial cells from hydrogen peroxide-induced oxidative stress. Evid Based Complement Altern Med 2015:957031.  https://doi.org/10.1155/2015/957031 CrossRefGoogle Scholar
  18. 18.
    Ferlazzo N, Visalli G, Cirmi S, Lombardo GE, Lagana P, Di Pietro A, Navarra M (2016) Natural iron chelators: protective role in A549 cells of flavonoids-rich extracts of citrus juices in Fe(3+)-induced oxidative stress. Environ Toxicol Pharmacol 43:248–256.  https://doi.org/10.1016/j.etap.2016.03.005 CrossRefGoogle Scholar
  19. 19.
    Curro M, Risitano R, Ferlazzo N, Cirmi S, Gangemi C, Caccamo D, Ientile R, Navarra M (2016) Citrus bergamia juice extract attenuates beta-amyloid-induced pro-inflammatory activation of THP-1 cells through MAPK and AP-1 pathways. Sci Rep 6:20809.  https://doi.org/10.1038/srep20809 CrossRefGoogle Scholar
  20. 20.
    Impellizzeri D, Cordaro M, Campolo M, Gugliandolo E, Esposito E, Benedetto F, Cuzzocrea S, Navarra M (2016) Anti-inflammatory and antioxidant effects of flavonoid-rich fraction of bergamot juice (BJe) in a mouse model of intestinal ischemia/reperfusion Injury. Front Pharmacol 7:203.  https://doi.org/10.3389/fphar.2016.00203 CrossRefGoogle Scholar
  21. 21.
    Impellizzeri D, Bruschetta G, Di Paola R, Ahmad A, Campolo M, Cuzzocrea S, Esposito E, Navarra M (2015) The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease. Clin Nutr 34(6):1146–1154.  https://doi.org/10.1016/j.clnu.2014.11.012 CrossRefGoogle Scholar
  22. 22.
    Caderni G, De Filippo C, Luceri C, Salvadori M, Giannini A, Biggeri A, Remy S, Cheynier V, Dolara P (2000) Effects of black tea, green tea and wine extracts on intestinal carcinogenesis induced by azoxymethane in F344 rats. Carcinogenesis 21(11):1965–1969CrossRefGoogle Scholar
  23. 23.
    Caderni G, Femia AP, Giannini A, Favuzza A, Luceri C, Salvadori M, Dolara P (2003) Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Cancer Res 63(10):2388–2392Google Scholar
  24. 24.
    Femia AP, Luceri C, Bianchini F, Salvadori M, Salvianti F, Pinzani P, Dolara P, Calorini L, Caderni G (2012) Marie Menard apples with high polyphenol content and a low-fat diet reduce 1,2-dimethylhydrazine-induced colon carcinogenesis in rats: effects on inflammation and apoptosis. Mol Nutr Food Res 56(8):1353–1357.  https://doi.org/10.1002/mnfr.201200122 CrossRefGoogle Scholar
  25. 25.
    Tortora K, Femia AP, Romagnoli A, Sineo I, Khatib M, Mulinacci N, Giovannelli L, Caderni G (2018) Pomegranate by-products in colorectal cancer chemoprevention: effects in Apc-mutated Pirc rats and mechanistic studies in vitro and ex vivo. Mol Nutr Food Res.  https://doi.org/10.1002/mnfr.201700401 Google Scholar
  26. 26.
    Mager LF, Wasmer MH, Rau TT, Krebs P (2016) Cytokine-induced modulation of colorectal cancer. Front Oncol 6:96.  https://doi.org/10.3389/fonc.2016.00096 CrossRefGoogle Scholar
  27. 27.
    Femia AP, Giannini A, Fazi M, Tarquini E, Salvadori M, Roncucci L, Tonelli F, Dolara P, Caderni G (2008) Identification of mucin depleted foci in the human colon. Cancer Prev Res 1(7):562–567.  https://doi.org/10.1158/1940-6207.CAPR-08-0125 CrossRefGoogle Scholar
  28. 28.
    Femia AP, Dolara P, Giannini A, Salvadori M, Biggeri A, Caderni G (2007) Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis. Cancer Res 67(2):445–449.  https://doi.org/10.1158/0008-5472.CAN-06-3861 CrossRefGoogle Scholar
  29. 29.
    Femia AP, Dolara P, Caderni G (2004) Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis. Carcinogenesis 25(2):277–281.  https://doi.org/10.1093/carcin/bgh005 CrossRefGoogle Scholar
  30. 30.
    Cirmi S, Ferlazzo N, Lombardo GE, Ventura-Spagnolo E, Gangemi S, Calapai G, Navarra M (2016) Neurodegenerative diseases: might citrus flavonoids play a protective role? Molecules.  https://doi.org/10.3390/molecules21101312 Google Scholar
  31. 31.
    Citraro R, Navarra M, Leo A, Donato Di Paola E, Santangelo E, Lippiello P, Aiello R, Russo E, De Sarro G (2016) The anticonvulsant activity of a flavonoid-rich extract from orange juice involves both NMDA and GABA-benzodiazepine receptor complexes. Molecules.  https://doi.org/10.3390/molecules21091261 Google Scholar
  32. 32.
    Cirmi S, Bisignano C, Mandalari G, Navarra M (2016) Anti-infective potential of Citrus bergamia Risso et Poiteau (bergamot) derivatives: a systematic review. Phytother Res 30(9):1404–1411.  https://doi.org/10.1002/ptr.5646 CrossRefGoogle Scholar
  33. 33.
    Celano M, Maggisano V, De Rose RF, Bulotta S, Maiuolo J, Navarra M, Russo D (2015) Flavonoid fraction of citrus reticulata juice reduces proliferation and migration of anaplastic thyroid carcinoma cells. Nutr Cancer 67(7):1183–1190.  https://doi.org/10.1080/01635581.2015.1073760 CrossRefGoogle Scholar
  34. 34.
    Fusco R, Cirmi S, Gugliandolo E, Di Paola R, Cuzzocrea S, Navarra M (2017) A flavonoid-rich extract of orange juice reduced oxidative stress in an experimental model of inflammatory bowel disease. J Funct Foods 30:168–178.  https://doi.org/10.1016/j.jff.2016.12.038 CrossRefGoogle Scholar
  35. 35.
    Filocamo A, Bisignano C, Ferlazzo N, Cirmi S, Mandalari G, Navarra M (2015) In vitro effect of bergamot (Citrus bergamia) juice against cagA-positive and-negative clinical isolates of Helicobacter pylori. BMC Complement Altern Med 15:256.  https://doi.org/10.1186/s12906-015-0769-2 CrossRefGoogle Scholar
  36. 36.
    Gugliandolo E, Fusco R, D’Amico R, Peditto M, Oteri G, Di Paola R, Cuzzocrea S, Navarra M (2018) Treatment with a flavonoid-rich fraction of bergamot juice improved lipopolysaccharide-induced periodontitis in rats. Front Pharmacol 9:1563.  https://doi.org/10.3389/fphar.2018.01563 CrossRefGoogle Scholar
  37. 37.
    Marino A, Paterniti I, Cordaro M, Morabito R, Campolo M, Navarra M, Cuzzocrea S (2015) Role of natural antioxidants and potential use of bergamot in treating rheumatoid arthritis. PharmaNutrition 3(2):53–59.  https://doi.org/10.1016/j.phanu.2015.03.002 CrossRefGoogle Scholar
  38. 38.
    Pesic M, Greten FR (2016) Inflammation and cancer: tissue regeneration gone awry. Curr Opin Cell Biol 43:55–61.  https://doi.org/10.1016/j.ceb.2016.07.010 CrossRefGoogle Scholar
  39. 39.
    Femia AP, Dolara P, Luceri C, Salvadori M, Caderni G (2009) Mucin-depleted foci show strong activation of inflammatory markers in 1,2-dimethylhydrazine-induced carcinogenesis and are promoted by the inflammatory agent sodium dextran sulfate. Int J Cancer 125(3):541–547.  https://doi.org/10.1002/ijc.24417 CrossRefGoogle Scholar
  40. 40.
    Warren CA, Paulhill KJ, Davidson LA, Lupton JR, Taddeo SS, Hong MY, Carroll RJ, Chapkin RS, Turner ND (2009) Quercetin may suppress rat aberrant crypt foci formation by suppressing inflammatory mediators that influence proliferation and apoptosis. J Nutr 139(1):101–105.  https://doi.org/10.3945/jn.108.096271 CrossRefGoogle Scholar
  41. 41.
    Zhang F, Wang H, Wang X, Jiang G, Liu H, Zhang G, Wang H, Fang R, Bu X, Cai S, Du J (2016) TGF-beta induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype. Oncotarget 7(32):52294–52306.  https://doi.org/10.18632/oncotarget.10561 Google Scholar
  42. 42.
    Kaler P, Augenlicht L, Klampfer L (2009) Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene 28(44):3892–3902.  https://doi.org/10.1038/onc.2009.247 CrossRefGoogle Scholar
  43. 43.
    Venkatachalam K, Gunasekaran S, Namasivayam N (2016) Biochemical and molecular mechanisms underlying the chemopreventive efficacy of rosmarinic acid in a rat colon cancer. Eur J Pharmacol 791:37–50.  https://doi.org/10.1016/j.ejphar.2016.07.051 CrossRefGoogle Scholar
  44. 44.
    Ravillah D, Mohammed A, Qian L, Brewer M, Zhang YT, Biddick L, Steele VE, Rao CV (2014) Chemopreventive effects of an HDAC2-selective inhibitor on rat colon carcinogenesis and APC(min/+) mouse intestinal tumorigenesis. J Pharmacol Exp Ther 348(1):59–68.  https://doi.org/10.1124/jpet.113.208645 CrossRefGoogle Scholar
  45. 45.
    Romanov VS, Pospelov VA, Pospelova TV (2012) Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis. Biochemistry (Moscow) 77(6):575–584.  https://doi.org/10.1134/S000629791206003x CrossRefGoogle Scholar
  46. 46.
    Sun SY, Hail N Jr, Lotan R (2004) Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst 96(9):662–672CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Chemical, Biological, Pharmaceutical and Environmental SciencesUniversity of MessinaMessinaItaly
  2. 2.Section of Pharmacology and Toxicology, NEUROFARBA DepartmentUniversity of FlorenceFlorenceItaly
  3. 3.Fondazione “Prof. Antonio Imbesi”MessinaItaly

Personalised recommendations